Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,390 | 2 | 85.9% |
| Food and Beverage | $214.16 | 7 | 13.2% |
| Education | $13.68 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $1,390 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $124.88 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $53.84 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $19.13 | 1 | $0 (2024) |
| PFIZER INC. | $15.00 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.99 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.13 | 1 | Janssen Pharmaceuticals, Inc ($19.13) |
| 2023 | $124.88 | 1 | AstraZeneca Pharmaceuticals LP ($124.88) |
| 2022 | $40.61 | 3 | Gilead Sciences, Inc. ($40.61) |
| 2021 | $28.23 | 2 | PFIZER INC. ($15.00) |
| 2020 | $1,405 | 3 | Genentech, Inc. ($1,390) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: Rare Disease | ||||||
| 08/24/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.07 | General |
| 06/08/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.86 | General |
| 06/07/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Education | In-kind items and services | $13.68 | General |
| Category: COVID-19 | ||||||
| 10/13/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.23 | General |
| 02/16/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2020 | Genentech, Inc. | Actemra (Biological) | Consulting Fee | Cash or cash equivalent | $695.00 | General |
| Category: Immunology | ||||||
| 06/27/2020 | Genentech, Inc. | Actemra (Biological) | Consulting Fee | Cash or cash equivalent | $695.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 320 | 650 | $732,992 | $99,589 |
| 2022 | 2 | 173 | 307 | $334,605 | $50,719 |
| 2021 | 3 | 222 | 432 | $439,022 | $76,180 |
| 2020 | 3 | 335 | 673 | $532,151 | $114,636 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 178 | 457 | $612,654 | $80,893 | 13.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 115 | 166 | $91,011 | $16,303 | 17.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 11 | 11 | $6,050 | $1,281 | 21.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 16 | 16 | $23,277 | $1,111 | 4.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 115 | 232 | $295,299 | $44,249 | 15.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 75 | $39,307 | $6,470 | 16.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 154 | 350 | $392,324 | $68,933 | 17.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 56 | 70 | $34,467 | $6,354 | 18.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 12 | 12 | $12,231 | $893.34 | 7.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 234 | 524 | $475,480 | $102,086 | 21.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 128 | $41,424 | $10,937 | 26.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 20 | 21 | $15,247 | $1,613 | 10.6% |
About Dr. Ronaldo Go, MD
Dr. Ronaldo Go, MD is a Critical Care Medicine healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336335710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronaldo Go, MD has received a total of $1,618 in payments from pharmaceutical and medical device companies, with $19.13 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,390).
As a Medicare-enrolled provider, Go has provided services to 1,050 Medicare beneficiaries, totaling 2,062 services with total Medicare billing of $341,124. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Hackensack, NJ
- Active Since 09/19/2007
- Last Updated 08/12/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1336335710
Products in Payments
- Actemra (Biological) $1,390
- ANDEXXA (Biological) $124.88
- XARELTO (Drug) $19.13
- ELIQUIS (Drug) $15.00
- STIOLTO RESPIMAT (Drug) $14.99
- Veklury (Drug) $13.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Hackensack
Eric Teller, Md, MD
Critical Care Medicine — Payments: $184,352
Dr. Raghad Said, Md, MD
Critical Care Medicine — Payments: $30,632
Eugene Bunnell, Md, MD
Critical Care Medicine — Payments: $6,225
Dr. Sean Mckay, M.d, M.D
Critical Care Medicine — Payments: $5,604
Dr. Fariborz Ashtyani, Md, MD
Critical Care Medicine — Payments: $4,361
Guido Barmaimon, M.d, M.D
Critical Care Medicine — Payments: $1,279